COVID-19
Gilead
Enrolling/Seeking Participants
This clinical trial will evaluate an investigational medication to help adults diagnosed with COVID-19 feel better faster. Researchers want to learn if the medication can shorten the length of time study participants have COVID-19 symptoms.
Principle Investigator: Dr. Christian Tomaszewski/ Sub-Investigator: Claudia Gonzalez-Tyler Pa-C
You may be eligible if you are:
- 18 to 64 years of age
- Have tested positive for COVID-19 in the last 3 days.
- Have had COVID-19 symptoms for no more than 3 days.
- Not be at risk for developing serious COVID-19 disease.
- Not admitted to the hospital or expecting to be admitted to the hospital.
Benefits of Participating:
- The study medications and related tests are provided at no cost to study participants.
- Compensation is available for time and travel.
- The knowledge that you are helping others.
Participant Details:
Participants will have laboratory tests done before and after the study medication or placebo is given. Participants are asked to complete a daily COVID-19 symptom diary during study participation. At least three in-person visits will be conducted at an ECRMC location.
For more information call:
Ericka Lara, Research Coordinator (760) 996-2448 or the Research Center (760) 370-8570
Or view online
